Kisspeptin
Kisspeptins are related peptides involved in reproductive regulation. Kisspeptin-10 and -54 are different molecular forms.
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Identity not confirmed
The name may refer to different substance or product forms.
Kisspeptin denotes several related peptides; kisspeptin-10 and kisspeptin-54 are not the same study form. This profile identifies the form only when the source specifies it.
Research areas
Evidence matrix
- Molecular identity
- Partially clarified
Kisspeptin denotes several related peptides; kisspeptin-10 and kisspeptin-54 are not the same study form. This profile identifies the form only when the source specifies it.
- Human research
- Limited
- Replication
- Single research group
- Clinical endpoints
- Symptom- or function-related
- Safety
- Limited characterization
- Approval
- No documented approval
The dimensions are presented separately and are not combined into an overall score.
What the source shows
The linked trial used kisspeptin-54 for oocyte maturation in IVF.
- Kisspeptin-54 and oocyte maturation: randomized phase 2 studyHuman study2017
U.S. National Library of Medicine (PubMed)
Accessed:
Research gaps
- ·Its results and amounts must not be transferred unchanged to kisspeptin-10.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
They influence the GnRH axis through the kisspeptin receptor.
- Kisspeptin-54 and oocyte maturation: randomized phase 2 studyHuman study2017
U.S. National Library of Medicine (PubMed)
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Safety has not been adequately studied.
Contraindications and warnings
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·Its results and amounts must not be transferred unchanged to kisspeptin-10.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- Kisspeptin-54 and oocyte maturation: randomized phase 2 studyHuman study2017
U.S. National Library of Medicine (PubMed)
Accessed:
Sources
Sources checked: · Version 2
- Kisspeptin-54 and oocyte maturation: randomized phase 2 studyHuman study2017
U.S. National Library of Medicine (PubMed)
Accessed: